Lindus Health launches Medical Device CRO offering.
READ MORE
"Lindus goes above and beyond to help tackle unexpected changes as they arise and provide exceptional services every step of the way.”
“In the past I’ve felt like most my interaction with CROs was about change orders; having a real partner with cost certainty is a game changer.”
“Working with Lindus has been a transformational experience. We would love to work with them again and again!”
"Lindus Health’s approach to clinical trial execution and their associated technologies should be incredibly helpful to biotech and pharmaceutical companies and enable them to bring new therapies to market faster and more efficiently."
“Working with the Lindus Health team has forever changed our experience running clinical trials. They have a can-do attitude and make things happen, going above and beyond the call of duty.”
“Lindus puts great emphasis on aligning incentives with sponsors, and their risk-sharing, milestone-based payment model is much needed in he CRO industry. Their patient and technology-centric approach to clinical trials will greatly benefit biotech and pharma companies, enabling faster, cost-effectve studies.”
"Lindus goes above and beyond to help tackle unexpected changes as they arise and provide exceptional services every step of the way.”
“In the past I’ve felt like most my interaction with CROs was about change orders; having a real partner with cost certainty is a game changer.”
“Working with Lindus has been a transformational experience. We would love to work with them again and again!”
“Working with the Lindus Health team has forever changed our experience running clinical trials. They have a can-do attitude and make things happen, going above and beyond the call of duty.”
"Lindus Health’s approach to clinical trial execution and their associated technologies should be incredibly helpful to biotech and pharmaceutical companies and enable them to bring new therapies to market faster and more efficiently."
“Lindus puts great emphasis on aligning incentives with sponsors, and their risk-sharing, milestone-based payment model is much needed in he CRO industry. Their patient and technology-centric approach to clinical trials will greatly benefit biotech and pharma companies, enabling faster, cost-effectve studies.”
We have experience spanning both common and rare indications. We’ve built a diverse team for our speciality Cardiovascular CRO offering that draws on years recruiting, managing, and treating patients in the Cardiovascular space. Get in touch with us for case studies matching your areas of study.
Let’s deliver better clinical trials together to get new treatments to patients faster.
Let’s deliver better clinical trials together to get new treatments to patients faster.
